NEW YORK, Sept. 06, 2022, a global leader in genomics and precision medicine, announced today that the Company has begun using needleless, at-home blood collection kitsfor its premium clinical whole genome
Investegate announcements from Dante Genomics, Dante Genomics to innovate universal genomics by now offering easy, at-home blood collection kits for clinical whole genome sequencing without the use of a needle
- ColoAlert to be marketed through Dante's extensive database and sold via its region-specific, ecommerce websites -BERKELEY, Calif. and MAINZ, Germany and NEW YORK, Aug. 16, 2022, a global leader in genomics
The partnership aims to enable universal access to genomic-driven wellness and longevityNEW YORK, June 22, 2022 (GLOBE NEWSWIRE) Emirates Post, the official postal operator and leading express provider